<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01880775</url>
  </required_header>
  <id_info>
    <org_study_id>OKabanPrilocain</org_study_id>
    <nct_id>NCT01880775</nct_id>
  </id_info>
  <brief_title>Discharge Conditions of Spinal Anesthesia With Heavy Prilocaine-Fentanyl and Heavy Bupivacaine-Fentanyl</brief_title>
  <official_title>The Comparison of the Discharge Conditions and Efficacy of Spinal Anesthesia With Heavy Prilocaine-Fentanyl and Heavy Bupivacaine-Fentanyl in Outpatient Minor Perianal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Teaching and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Teaching and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective randomized study the investigators aimed to investigate difference of the
      duration of spinal anesthesia, discharge times and efficacy between low dose heavy
      Prilocaine-Fentanyl and heavy Bupivacaine-Fentanyl in outpatient minor anal surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ASA status I-III patients will be recruited. Patients will be randomized in two groups. Group
      B will be received 1.5 ml heavy bupivacaine+ 20 mic fentanyl+ 0.15 ml and Group P will be
      received 1,5 ml heavy prilocaine+20 mic fentanyl in the same volume.Patients will be
      monitored with electrocardiography, peripheral oxygen saturation(sPO2) and non invasive blood
      pressure (Drager Infinity Delta; 16 Electronics Avenue, Danvers, MA 01923 USA). After
      inserting a 20 G intravenous line the patients will be hydrated with 10 ml/kg 0.9 % saline.

      Preoperative systolic blood pressure (SBP), diastolic blood pressure (DBP), mean blood
      pressure (MBP), heart rate (HR) and Spo2 will be measured and recorded.

      Spinal anesthesia will be commenced in the sitting position with a 25 G Quincke needle, with
      the midline approach. After observing free flow of cerebrospinal fluid the prepared study
      drug will be injected in 15 seconds. The patients will be placed supine after waiting 2
      minute in the sitting position. Supplemental oxygen via nasal cannula will be provided.

      Fentanyl and midazolam will be used for rescue analgesia and sedation and recorded.

      Sensorial block will be assessed with pinprick test with 2 minute intervals until the maximum
      block achieves and with 15 minute intervals until the block was regresses to S3 dermatome.
      Motor block will be assessed with the Bromage score when the block reached the maximum level.
      Patients will be transferred to postoperative care unit (PACU) at he end of surgery.

      Pain will be assessed on a 10 point visual analog scale (VAS)(0= no pain, 10= worst pain
      ever). Postoperative analgesia will be provided with 2 mg.kg-1 tramadol or 15 mg.kg-1
      paracetamol when the VAS score is ≥3 time of first analgesic request will be recorded.

      Hypotension (≥20% reduced from baseline values) will be treated with ephedrine or iv fluid
      boluses), bradycardia (HR&lt;45 beat min-1 was treated with atropine) was recorded.

      The patients will be asked whether to void before surgery. Bladder volume will be assessed
      with ultrasonography. Patients with residual bladder volumes ≥400 ml will be placed an urine
      catheter. Time to first urinate will be recorded.

      Patients will be assessed for transient neurologic symptoms(pain in the buttocks and
      legs)(TNS) and satisfaction after surgery.

      TNS will be evaluated with daily telephone calls. Patient satisfaction will be evaluated with
      global satisfaction scale (1= bad, 2=not satisfied, 3=have no idea, 4=satisfied, 5=very
      satisfied) Parameters to record; time of entering operation room, duration of surgery, time
      of intrathecal injection, onset of sensorial block(block at L1), time to reach maximum block
      level, maximum block level, first analgesic ingestion time, PACU duration, two segment
      regression, time to L1 regression, time to S3 regression, time to it without help, time to
      stand up without help, time to walk without help, discharge time, time to first void. TNS,
      patient satisfaction score.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensory block regression at S3 (time, minute)</measure>
    <time_frame>postoperative 30. minute</time_frame>
    <description>spinal anesthesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>discharge time (minute)</measure>
    <time_frame>postoperative 2 hour</time_frame>
    <description>spinal anesthesia</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Maximum block height</measure>
    <time_frame>Intraoperative 30 minutes</time_frame>
    <description>Maximum spread of the sensorial block</description>
  </other_outcome>
  <other_outcome>
    <measure>Motor block</measure>
    <time_frame>Intraoperative 30 minutes and postoperative first hour</time_frame>
    <description>Bromage scale will be used 0: no motor block, 1: hip blocked, 2: hip and knee blocked, 3: hip, knee and ankle blocked</description>
  </other_outcome>
  <other_outcome>
    <measure>Regression of motor block</measure>
    <time_frame>Postoperative second hour</time_frame>
    <description>Bromage scale will be used 0: no motor block, 1: hip blocked, 2: hip and knee blocked, 3: hip, knee and ankle blocked</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to L1 block</measure>
    <time_frame>Intraoperative 5 minutes</time_frame>
    <description>Loss of sensation to pin prick</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to T10 block</measure>
    <time_frame>Introperative 10 minute</time_frame>
    <description>loss of sensation to pinprick</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Hemorrhoid</condition>
  <condition>Peri Anal Fistula</condition>
  <arm_group>
    <arm_group_label>prilocaine heavy 2%&amp; fentanyl</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>prilocaine heavy 2% 30 mg and fentanyl 20 micgr ampoule intrathecal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bupivacaine heavy 0.5% &amp; fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>bupivacaine heavy 0.5% 7.5 mg and fentanyl 20 micg ampoule intrathecal</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prilocaine</intervention_name>
    <description>experimental</description>
    <arm_group_label>prilocaine heavy 2%&amp; fentanyl</arm_group_label>
    <other_name>prilothecal</other_name>
    <other_name>citanest</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>marcaine heavy 0.5% 7.5 mg intrathecal</description>
    <arm_group_label>bupivacaine heavy 0.5% &amp; fentanyl</arm_group_label>
    <other_name>marcaine heavy 0.5%</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA status I-III

        Exclusion Criteria:

          -  Patients with contraindications for spinal anesthesia,

          -  hypersensitivity to study drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taylan Akkaya, Assoc Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Netherlands: Ministry of Health, Welfare and Sports</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diskapi Yildirim Beyazit Training and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06110</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Camponovo C, Fanelli A, Ghisi D, Cristina D, Fanelli G. A prospective, double-blinded, randomized, clinical trial comparing the efficacy of 40 mg and 60 mg hyperbaric 2% prilocaine versus 60 mg plain 2% prilocaine for intrathecal anesthesia in ambulatory surgery. Anesth Analg. 2010 Aug;111(2):568-72. doi: 10.1213/ANE.0b013e3181e30bb8. Epub 2010 Jun 7.</citation>
    <PMID>20529983</PMID>
  </reference>
  <reference>
    <citation>Black AS, Newcombe GN, Plummer JL, McLeod DH, Martin DK. Spinal anaesthesia for ambulatory arthroscopic surgery of the knee: a comparison of low-dose prilocaine and fentanyl with bupivacaine and fentanyl. Br J Anaesth. 2011 Feb;106(2):183-8. doi: 10.1093/bja/aeq272. Epub 2010 Oct 14.</citation>
    <PMID>20947591</PMID>
  </reference>
  <reference>
    <citation>Ostgaard G, Hallaråker O, Ulveseth OK, Flaatten H. A randomised study of lidocaine and prilocaine for spinal anaesthesia. Acta Anaesthesiol Scand. 2000 Apr;44(4):436-40.</citation>
    <PMID>10757577</PMID>
  </reference>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2012</study_first_submitted>
  <study_first_submitted_qc>June 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2013</study_first_posted>
  <last_update_submitted>June 2, 2014</last_update_submitted>
  <last_update_submitted_qc>June 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diskapi Teaching and Research Hospital</investigator_affiliation>
    <investigator_full_name>Ozden Gorgoz Kaban</investigator_full_name>
    <investigator_title>Medical Doctor Trainee in Anesthesiology and Reanimation</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Hemorrhoids</mesh_term>
    <mesh_term>Rectal Fistula</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Prilocaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

